Nasdaq Imab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq imab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Imab Today - Breaking & Trending Today

Needham & Company LLC Reaffirms Buy Rating for I-Mab (NASDAQ:IMAB)

I-Mab (NASDAQ:IMAB – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at Needham & Company LLC in a research report issued on Friday, Benzinga reports. They currently have a $6.00 target price on the stock. Needham & Company LLC’s price objective suggests a potential upside of 231.49% from the stock’s previous […] ....

United States , Piper Sandler , Goldman Sachs Group Inc , Needham Company , Cantor Fitzgerald , Blackrock Inc , America Corp , Jpmorgan Chase Co , Company Profile , Vanguard Group Inc , Get Free Report , Mab Trading Down , Sachs Group , I Mab Daily , I Mab , Nasdaq Imab , Reiterated Rating , Needham Amp Company Llc ,

Reviewing I-Mab (NASDAQ:IMAB) and Cerevel Therapeutics (NASDAQ:CERE)

I-Mab (NASDAQ:IMAB – Get Free Report) and Cerevel Therapeutics (NASDAQ:CERE – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends and profitability. Institutional & Insider Ownership 22.6% of I-Mab shares are […] ....

United Kingdom , United States , Kalbe Genexine Biologics , Abbvie Ireland Unlimited Company , Sinopharm Group Co , Jumpcan Pharmaceutical Group , Cerevel Therapeutics Holdings Inc , Get Free Report , Cerevel Therapeutics , Giveni Mab , Cerevel Therapeutic , Genexine Biologics , Sinopharm Group , Therapeutics Holdings , I Mab Daily , I Mab , Nasdaq Imab , Stock Comparison , Stock Analysis ,

Cantor Fitzgerald Reaffirms Overweight Rating for I-Mab (NASDAQ:IMAB)

Cantor Fitzgerald restated their overweight rating on shares of I-Mab (NASDAQ:IMAB – Free Report) in a research report report published on Monday morning, PriceTargets.com reports. Cantor Fitzgerald also issued estimates for I-Mab’s FY2023 earnings at ($1.85) EPS and FY2024 earnings at ($1.14) EPS. Separately, Needham & Company LLC dropped their price target on shares of […] ....

Hong Kong , Panagora Asset Management Inc , Fund Management Hong Kong Co , Cantor Fitzgerald , Citigroup Inc , Jpmorgan Chase Co , Company Profile , E Fund Management Hong Kong Co , Needham Company , Acadian Asset Management , Free Report , Fund Management Hong Kong , Asset Management , Panagora Asset Management , Get Free Report , I Mab Daily , I Mab , Nasdaq Imab , Reiterated Rating ,

I-Mab (NASDAQ:IMAB) Given New $23.00 Price Target at Needham & Company LLC

I-Mab (NASDAQ:IMAB – Free Report) had its price objective lowered by Needham & Company LLC from $24.00 to $23.00 in a report published on Monday, Marketbeat.com reports. The firm currently has a buy rating on the stock. Several other brokerages have also recently issued reports on IMAB. HC Wainwright lowered their price target on shares […] ....

Needham Company , Acadian Asset Management , Topco Ltd , Cantor Fitzgerald , Company Profile , Exchange Traded Concepts , Sei Investments Co , Free Report , Mab Trading Down , Asset Management , Get Free Report , I Mab Daily , I Mab , Nasdaq Imab , Lower Price Target , Needham Company Llc ,

I-Mab (NASDAQ:IMAB) Price Target Lowered to $18.00 at HC Wainwright

I-Mab (NASDAQ:IMAB – Free Report) had its target price decreased by HC Wainwright from $25.00 to $18.00 in a report issued on Friday morning, Marketbeat reports. HC Wainwright currently has a buy rating on the stock. Separately, Needham & Company LLC restated a buy rating and issued a $24.00 price objective on shares of I-Mab […] ....

Company Profile , Needham Company , Renaissance Technologies , Mackenzie Financial Corp , Exchange Traded Concepts , Jpmorgan Chase Co , Blackrock Inc , Free Report , Financial Corp , Get Free Report , I Mab Daily , I Mab , Nasdaq Imab , Lower Price Target , Hc Wainwright ,